Frontier Medicines is discovering and developing breakthrough medicines that redefine the course of debilitating diseases.

LEARN MORE

Frontier Medicines’ integrated approach leverages chemoproteomics and machine learning to accelerate the development of medicines that drug the “undruggable” protein targets that drive human disease.

Media Coverage

June 26, 2019

WSJ Venture Capital: Biotech Entrepreneur Chris Varma Scores $67 Million for Frontier Medicines
Read article

June 26, 2019

Fierce Biotech: Frontier Medicines Launches with $67M and Biotech Veteran Varma as CEO
Read article

June 26, 2019

BioWorld: Frontier Medicines Launches with a $67M Series A Round
Read article

June 26, 2019

BioCentury: Frontier Aims for Previously Unreachable 'Hot Spot' Targets with $67M Series A
Read article

June 26, 2019

C&EN: Frontier Medicines Launches with $67 Million in Funding
Read article

June 26, 2019

Silicon Valley Business Journal: How an Entrepreneur with UC Technology is on the Trail Toward the 'Undruggable'
Read article